|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carninci P, Kasukawa T, Katayama S, Gough
J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al:
FANTOM Consortium; RIKEN Genome Exploration Research Group and
Genome Science Group (Genome Network Project Core Group): The
transcriptional landscape of the mammalian genome. Science.
309:1559–1563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Michalak P: RNA world - the dark matter of
evolutionary genomics. J Evol Biol. 19:1768–1774. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs, Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tiedge H, Chen W and Brosius J: Primary
structure, neural-specific expression, and dendritic location of
human BC200 RNA. J Neurosci. 13:2382–2390. 1993.PubMed/NCBI
|
|
8
|
Wang H, Iacoangeli A, Popp S, Muslimov IA,
Imataka H, Sonenberg N, Lomakin IB and Tiedge H: Dendritic BC1 RNA,
Functional role in regulation of translation initiation. J
Neurosci. 22:10232–10241. 2002.PubMed/NCBI
|
|
9
|
Chen W, Böcker W, Brosius J and Tiedge H:
Expression of neural BC200 RNA in human tumours. J Pathol.
183:345–351. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brunner AL, Beck AH, Edris B, Sweeney RT,
Zhu SX, Li R, Montgomery K, Varma S, Gilks T, Guo X, et al:
Transcriptional profiling of long non-coding RNAs and novel
transcribed regions across a diverse panel of archived human
cancers. Genome Biol. 13:R752012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tano K, Mizuno R, Okada T, Rakwal R,
Shibato J, Masuo Y, Ijiri K and Akimitsu N: MALAT-1 enhances cell
motility of lung adenocarcinoma cells by influencing the expression
of motility-related genes. FEBS Lett. 584:4575–4580. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tanos V, Prus D, Ayesh S, Weinstein D,
Tykocinski ML, De-Groot N, Hochberg A and Ariel I: Expression of
the imprinted H19 oncofetal RNA in epithelial ovarian cancer. Eur J
Obstet Gynecol Reprod Biol. 85:7–11. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Benoît MH, Hudson TJ, Maire G, Squire JA,
Arcand SL, Provencher D, Mes-Masson AM and Tonin PN: Global
analysis of chromosome X gene expression in primary cultures of
normal ovarian surface epithelial cells and epithelial ovarian
cancer cell lines. Int J Oncol. 30:5–17. 2007.PubMed/NCBI
|
|
17
|
Silva JM, Boczek NJ, Berres MW, Ma X and
Smith DI: LSINCT5 is over expressed in breast and ovarian cancer
and affects cellular proliferation. RNA Biol. 8:496–505. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guan Y, Kuo WL, Stilwell JL, Takano H,
Lapuk AV, Fridlyand J, Mao JH, Yu M, Miller MA, Santos JL, et al:
Amplification of PVT1 contributes to the pathophysiology of ovarian
and breast cancer. Clin Cancer Res. 13:5745–5755. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hussein-Fikret S and Fuller PJ: Expression
of nuclear receptor coregulators in ovarian stromal and epithelial
tumours. Mol Cell Endocrinol. 229:149–160. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rangel LB, Sherman-Baust CA, Wernyj RP,
Schwartz DR, Cho KR and Morin PJ: Characterization of novel human
ovarian cancer-specific transcripts (HOSTs) identified by serial
analysis of gene expression. Oncogene. 22:7225–7232. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mizrahi A, Czerniak A, Levy T, Amiur S,
Gallula J, Matouk I, Abu-lail R, Sorin V, Birman T, de Groot N, et
al: Development of targeted therapy for ovarian cancer mediated by
a plasmid expressing diphtheria toxin under the control of H19
regulatory sequences. J Transl Med. 7:692009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang KC, Rao PH, Lau CC, Heard E, Ng SK,
Brown C, Mok SC, Berkowitz RS and Ng SW: Relationship of XIST
expression and responses of ovarian cancer to chemotherapy. Mol
Cancer Ther. 1:769–776. 2002.PubMed/NCBI
|
|
23
|
Liu SP, Yang JX, Cao DY and Shen K:
Identification of differentially expressed long non-coding RNAs in
human ovarian cancer cells with different metastatic potentials.
Cancer Biol Med. 10:138–141. 2013.PubMed/NCBI
|
|
24
|
Gao Y, Meng H, Liu S, Hu J, Zhang Y, Jiao
T, Liu Y, Ou J, Wang D, Yao L, et al: LncRNA-HOST2 regulates cell
biological behaviors in epithelial ovarian cancer through a
mechanism involving microRNA let-7b. Hum Mol Genet. 24:841–852.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Watson JB and Sutcliffe JG: Primate
brain-specific cytoplasmic transcript of the Alu repeat family. Mol
Cell Biol. 7:3324–3327. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McKinnon RD, Danielson P, Brow MA, Bloom
FE and Sutcliffe JG: Expression of small cytoplasmic transcripts of
the rat identifier element in vivo and in cultured cells. Mol Cell
Biol. 7:2148–2154. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu KH, Li W, Liu XH, Sun M, Zhang ML, Wu
WQ, Xie WP and Hou YY: Long non-coding RNA MEG3 inhibits NSCLC
cells proliferation and induces apoptosis by affecting p53
expression. BMC Cancer. 13:4612013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA, A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fan M, Li X, Jiang W, Huang Y, Li J and
Wang Z: A long non-coding RNA, PTCSC3, as a tumor suppressor and a
target of miRNAs in thyroid cancer cells. Exp Ther Med.
5:1143–1146. 2013.PubMed/NCBI
|
|
30
|
Jendrzejewski J, He H, Radomska HS, Li W,
Tomsic J, Liyanarachchi S, Davuluri RV, Nagy R and de la Chapelle
A: The polymorphism rs944289 predisposes to papillary thyroid
carcinoma through a large intergenic noncoding RNA gene of tumor
suppressor type. Proc Natl Acad Sci USA. 109:8646–8651. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Iacoangeli A, Lin Y, Morley EJ, Muslimov
IA, Bianchi R, Reilly J, Weedon J, Diallo R, Böcker W and Tiedge H:
BC200 RNA in invasive and preinvasive breast cancer.
Carcinogenesis. 25:2125–2133. 2004. View Article : Google Scholar : PubMed/NCBI
|
